## Core Concept
The question tests the understanding of genetic testing methods, specifically chorionic villus sampling (CVS) and amniocentesis, and their limitations in detecting certain genetic conditions. These procedures involve analyzing the DNA of cells obtained from the placenta (CVS) or amniotic fluid (amniocentesis) to identify genetic abnormalities.

## Why the Correct Answer is Right
The correct answer, , implies a condition that is not typically detectable through DNA analysis of chorionic villus or amniocentesis. These tests are primarily used to detect chromosomal abnormalities (like Down syndrome), single-gene disorders, and certain genetic mutations. However, they may not detect conditions caused by mutations in mitochondrial DNA or certain types of mosaicism that are not present in the sampled cells.

## Why Each Wrong Option is Incorrect
* **Option A:** - This option is incorrect because many chromosomal abnormalities can indeed be detected through CVS and amniocentesis, as these tests analyze the chromosomal content of the sampled cells.
* **Option B:** - This option is incorrect because single-gene disorders, which are caused by mutations in specific genes, can often be identified through genetic testing of CVS or amniocentesis samples.
* **Option C:** - This option is incorrect as certain genetic mutations can be detected through these tests, especially if the mutation is present in the cells sampled.

## Clinical Pearl / High-Yield Fact
A key point to remember is that while CVS and amniocentesis can detect many genetic conditions, they may not identify all types of genetic mutations or conditions, especially those that are mosaic (i.e., present in only some cells) or caused by mutations in mitochondrial DNA.

## Correct Answer: D.